Strides Pharma Science Ltd - Multiyear Breakout returns -2-3X !!
The price consolidation for last 9 years gave a breakout which retested the breakout levels and going upwards. The price may move to give high returns in coming time.
Technically Multiyear breakout (double bottom) and may rise the price to give multibagger return after short consolidation.
Stock details
Sector: Pharma
Theme play out: CDMO ( Contract Development and Manufacturing Organization)
Technical analysis details
Accumulation Zone= 1350-1675
Low-risk entry price = weekly closing candle >1675
Stoploss = 1235 (weekly closing for less risk takers)
Stoploss = 1000 (weekly closing below- high-risk takers)
Target 1 = 2000
Target 2 = 2500
Target 3 = 3000
Target 4 = 4500 (Time frame ~ 1-4 years)
Positives
FII holding = 30.08%
DII Holding = 18.24%
sales are increasing annually
CDMO theme
Negatives
Promoters sold their holding 4.67 % for the last 3 years
Promoters pledge to hold 49.2%
Debt > reserves
Disclaimer: This analysis is just for educational purpose; nothing is guaranteed;
Technically Multiyear breakout (double bottom) and may rise the price to give multibagger return after short consolidation.
Stock details
Sector: Pharma
Theme play out: CDMO ( Contract Development and Manufacturing Organization)
Technical analysis details
Accumulation Zone= 1350-1675
Low-risk entry price = weekly closing candle >1675
Stoploss = 1235 (weekly closing for less risk takers)
Stoploss = 1000 (weekly closing below- high-risk takers)
Target 1 = 2000
Target 2 = 2500
Target 3 = 3000
Target 4 = 4500 (Time frame ~ 1-4 years)
Positives
FII holding = 30.08%
DII Holding = 18.24%
sales are increasing annually
CDMO theme
Negatives
Promoters sold their holding 4.67 % for the last 3 years
Promoters pledge to hold 49.2%
Debt > reserves
Disclaimer: This analysis is just for educational purpose; nothing is guaranteed;
Dagangan aktif
one More Negative: Stock P/E is higher than average industry P/EPesanan dibatalkan
Target levels are not valid as stock got demerged with another company evolving from this stock price
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.